Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Aug 30;11(8):e007118. doi: 10.1136/jitc-2023-007118

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.

PMC Copyright notice

Duration of remission (censored at subsequent alloSCT) in Phase 1 and 2 treated patients by (A) prior number of therapy lines, (B) prior blinatumomab exposure, (C) prior inotuzumab exposure, and (D) prior alloSCT exposure. Kaplan-Meier estimates of the duration of remission by central assessment, with censoring of patients at subsequent alloSCT. alloSCT, allogeneic stem cell transplantation; CR, complete remission; CRi, complete remission with incomplete hematological recovery; mo, month; NE, not estimable; No, number; NR, not reached.